Daewoong Pharma historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2026-10-19 | 105,300.00 | 108,500.00 | 104,000.00 | 107,800.00 | 107,800.00 | 16,428 |
| 2026-10-16 | 105,600.00 | 109,600.00 | 105,000.00 | 105,000.00 | 105,000.00 | 21,380 |
| 2026-10-15 | 106,400.00 | 106,500.00 | 102,000.00 | 105,000.00 | 105,000.00 | 26,096 |
| 2026-10-14 | 106,300.00 | 108,400.00 | 105,800.00 | 106,600.00 | 106,600.00 | 16,738 |
| 2026-10-13 | 104,100.00 | 107,400.00 | 101,900.00 | 107,300.00 | 107,300.00 | 38,045 |
| 2026-10-12 | 107,500.00 | 109,900.00 | 102,200.00 | 103,600.00 | 103,600.00 | 29,519 |
| 2026-10-08 | 108,500.00 | 110,600.00 | 107,400.00 | 108,500.00 | 108,500.00 | 26,034 |
| 2026-10-07 | 110,100.00 | 111,100.00 | 109,400.00 | 110,400.00 | 110,400.00 | 10,061 |
| 2026-10-06 | 108,700.00 | 110,500.00 | 107,600.00 | 109,300.00 | 109,300.00 | 15,704 |
| 2026-10-02 | 110,900.00 | 110,900.00 | 106,900.00 | 109,000.00 | 109,000.00 | 15,122 |
| 2026-10-01 | 107,300.00 | 110,300.00 | 106,000.00 | 109,600.00 | 109,600.00 | 21,398 |
| 2026-09-30 | 107,400.00 | 107,900.00 | 105,800.00 | 106,300.00 | 106,300.00 | 12,634 |
| 2026-09-29 | 108,300.00 | 108,300.00 | 104,900.00 | 107,300.00 | 107,300.00 | 19,466 |
| 2026-09-28 | 106,900.00 | 109,050.00 | 106,800.00 | 108,300.00 | 108,300.00 | 11,250 |
| 2026-09-23 | 109,600.00 | 109,700.00 | 106,000.00 | 106,200.00 | 106,200.00 | 14,399 |
| 2026-09-22 | 108,500.00 | 110,000.00 | 107,900.00 | 108,800.00 | 108,800.00 | 15,299 |
| 2026-09-21 | 109,800.00 | 109,900.00 | 108,100.00 | 108,300.00 | 108,300.00 | 10,234 |
Page 1 of 1 · 17 trading days
Stock splits
No stock splits on record.
Dividends
| Ex-date | Amount |
|---|---|
| 2025-12-29 | 600.0000 KRW |
| 2024-12-27 | 600.0000 KRW |
| 2022-12-28 | 600.0000 KRW |
| 2021-12-29 | 600.0000 KRW |
| 2020-12-29 | 600.0000 KRW |
| 2019-12-27 | 600.0000 KRW |
Open, high, low and close are as traded (KRW). Adjusted close accounts for splits and dividends. Educational only, not financial advice.